{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T06:01:06Z","timestamp":1772776866701,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,19]],"date-time":"2021-12-19T00:00:00Z","timestamp":1639872000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,19]],"date-time":"2021-12-19T00:00:00Z","timestamp":1639872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Parental donor kidney transplantation is the most common treatment option for children and adolescents with kidney failure. Emerging data from observational studies have reported improved short- and medium-term allograft outcomes in recipients of paternal compared to maternal donors. The INCEPTION study aims to identify potential differences in immunological compatibility between maternal and paternal donor kidneys and ascertain how this affects kidney allograft outcomes in children and adolescents with kidney failure.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This longitudinal observational study will recruit kidney transplant recipients aged \u226418\u2009years who have received a parental donor kidney transplant across 4 countries (Australia, New Zealand, United Kingdom and the Netherlands) between 1990 and 2020. High resolution human leukocyte antigen (HLA) typing of both recipients and corresponding parental donors will be undertaken, to provide an in-depth assessment of immunological compatibility. The primary outcome is a composite of de novo donor-specific anti-HLA antibody (DSA), biopsy-proven acute rejection or allograft loss up to 60-months post-transplantation. Secondary outcomes are de novo DSA, biopsy-proven acute rejection, acute or chronic antibody mediated rejection or Chronic Allograft Damage Index (CADI) score of &gt;\u20091 on allograft biopsy post-transplant, allograft function, proteinuria and allograft loss. Using principal component analysis and Cox proportional hazards regression modelling, we will determine the associations between defined sets of immunological and clinical parameters that may identify risk stratification for the primary and secondary outcome measures among young people accepting a parental donor kidney for transplantation. This study design will allow us to specifically investigate the relative importance of accepting a maternal compared to paternal donor, for families deciding on the best option for donation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>The INCEPTION study findings will explore potentially differential immunological risks of maternal and paternal donor kidneys for transplantation among children and adolescents. Our study will provide the evidence base underpinning the selection of parental donor in order to achieve the best projected long-term kidney transplant and overall health outcomes for children and adolescents, a recognized vulnerable population.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>The INCEPTION study has been registered with the Australian New Zealand Clinical Trials Registry, with the trial registration number of <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=380039&amp;isReview=true\">ACTRN12620000911998<\/jats:ext-link> (14th September 2020).<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12882-021-02619-0","type":"journal-article","created":{"date-parts":[[2021,12,19]],"date-time":"2021-12-19T05:02:38Z","timestamp":1639890158000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Improve in-depth immunological risk assessment to optimize genetic-compatibility and clinical outcomes in child and adolescent recipients of parental donor kidney transplants: protocol for the INCEPTION study"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3410-3572","authenticated-orcid":false,"given":"Wai H.","family":"Lim","sequence":"first","affiliation":[]},{"given":"Brigitte","family":"Adams","sequence":"additional","affiliation":[]},{"given":"Stephen","family":"Alexander","sequence":"additional","affiliation":[]},{"given":"Antonia H. M.","family":"Bouts","sequence":"additional","affiliation":[]},{"given":"Frans","family":"Claas","sequence":"additional","affiliation":[]},{"given":"Michael","family":"Collins","sequence":"additional","affiliation":[]},{"given":"Elisabeth","family":"Cornelissen","sequence":"additional","affiliation":[]},{"given":"Heather","family":"Dunckley","sequence":"additional","affiliation":[]},{"given":"Huib","family":"de Jong","sequence":"additional","affiliation":[]},{"given":"Lloyd","family":"D\u2019Orsogna","sequence":"additional","affiliation":[]},{"given":"Anna","family":"Francis","sequence":"additional","affiliation":[]},{"given":"Sebastiaan","family":"Heidt","sequence":"additional","affiliation":[]},{"given":"Jean","family":"Herman","sequence":"additional","affiliation":[]},{"given":"Rhonda","family":"Holdsworth","sequence":"additional","affiliation":[]},{"given":"Joshua","family":"Kausman","sequence":"additional","affiliation":[]},{"given":"Rabia","family":"Khalid","sequence":"additional","affiliation":[]},{"given":"Jon Jin","family":"Kim","sequence":"additional","affiliation":[]},{"given":"Siah","family":"Kim","sequence":"additional","affiliation":[]},{"given":"No\u00ebl","family":"Knops","sequence":"additional","affiliation":[]},{"given":"Vasilis","family":"Kosmoliaptsis","sequence":"additional","affiliation":[]},{"given":"Cynthia","family":"Kramer","sequence":"additional","affiliation":[]},{"given":"Dirk","family":"Kuypers","sequence":"additional","affiliation":[]},{"given":"Nicholas","family":"Larkins","sequence":"additional","affiliation":[]},{"given":"Suetonia C.","family":"Palmer","sequence":"additional","affiliation":[]},{"given":"Chanel","family":"Prestidge","sequence":"additional","affiliation":[]},{"given":"Agnieszka","family":"Prytula","sequence":"additional","affiliation":[]},{"given":"Ankit","family":"Sharma","sequence":"additional","affiliation":[]},{"given":"Meena","family":"Shingde","sequence":"additional","affiliation":[]},{"given":"Anne","family":"Taverniti","sequence":"additional","affiliation":[]},{"given":"Armando","family":"Teixeira-Pinto","sequence":"additional","affiliation":[]},{"given":"Peter","family":"Trnka","sequence":"additional","affiliation":[]},{"given":"Francis","family":"Willis","sequence":"additional","affiliation":[]},{"given":"Daniel","family":"Wong","sequence":"additional","affiliation":[]},{"given":"Germaine","family":"Wong","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2021,12,19]]},"reference":[{"key":"2619_CR1","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1056\/NEJM199912023412303","volume":"341","author":"RA Wolfe","year":"1999","unstructured":"Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 1999;341:1725\u201330.","journal-title":"N Engl J Med"},{"key":"2619_CR2","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1097\/00007890-200211270-00005","volume":"74","author":"HU Meier-Kriesche","year":"2002","unstructured":"Meier-Kriesche HU, Kaplan B. Waiting time on dialysis as the strongest modifiable risk factor for renal transplant outcomes: a paired donor kidney analysis. Transplantation. 2002;74:1377\u201381.","journal-title":"Transplantation"},{"key":"2619_CR3","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1056\/NEJM200103083441004","volume":"344","author":"KC Mange","year":"2001","unstructured":"Mange KC, Joffe MM, Feldman HI. Effect of the use or nonuse of long-term dialysis on the subsequent survival of renal transplants from living donors. N Engl J Med. 2001;344:726\u201331.","journal-title":"N Engl J Med"},{"key":"2619_CR4","doi-asserted-by":"publisher","first-page":"e13265","DOI":"10.1111\/petr.13265","volume":"22","author":"P Trnka","year":"2018","unstructured":"Trnka P, McTaggart SJ, Francis A. The impact of donor\/recipient age difference and HLA mismatch on graft outcome in pediatric kidney transplantation. Pediatr Transplant. 2018;22:e13265.","journal-title":"Pediatr Transplant"},{"key":"2619_CR5","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1097\/TP.0000000000000469","volume":"99","author":"WH Lim","year":"2015","unstructured":"Lim WH, Chapman JR, Wong G. Peak panel reactive antibody, cancer, graft, and patient outcomes in kidney transplant recipients. Transplantation. 2015;99:1043\u201350.","journal-title":"Transplantation"},{"key":"2619_CR6","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1111\/tri.13418","volume":"32","author":"L Mumford","year":"2019","unstructured":"Mumford L, Maxwell H, Ahmad N, Marks SD, Tizard J. The impact of changing practice on improved outcomes of paediatric renal transplantation in the United Kingdom: a 25 years review. Transpl Int. 2019;32:751\u201361.","journal-title":"Transpl Int"},{"key":"2619_CR7","volume-title":"Chapter 11: paediatric patients with end stage kidney disease requiring renal replacement therapy. Adelaide, Australia","author":"Australia and New Zealand Dialysis and Transplant Registry Report","year":"2018","unstructured":"Australia and New Zealand Dialysis and Transplant Registry Report. Chapter 11: paediatric patients with end stage kidney disease requiring renal replacement therapy. Adelaide, Australia. 2018."},{"key":"2619_CR8","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.kint.2015.11.016","volume":"89","author":"WH Lim","year":"2016","unstructured":"Lim WH, McDonald SP, Coates PT, Chapman JR, Russ GR, Wong G. Maternal compared with paternal donor kidneys are associated with poorer graft outcomes after kidney transplantation. Kidney Int. 2016;89:659\u201365.","journal-title":"Kidney Int"},{"key":"2619_CR9","doi-asserted-by":"publisher","first-page":"5554","DOI":"10.4049\/jimmunol.171.10.5554","volume":"171","author":"J Andrassy","year":"2003","unstructured":"Andrassy J, Kusaka S, Jankowska-Gan E, et al. Tolerance to noninherited maternal MHC antigens in mice. J Immunol. 2003;171:5554\u201361.","journal-title":"J Immunol"},{"key":"2619_CR10","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1097\/00007890-198404000-00004","volume":"37","author":"DA Campbell Jr","year":"1984","unstructured":"Campbell DA Jr, Lorber MI, Sweeton JC, Turcotte JG, Niederhuber JE, Beer AE. Breast feeding and maternal-donor renal allografts. Possibly the original donor-specific transfusion. Transplantation. 1984;37:340\u20134.","journal-title":"Transplantation"},{"key":"2619_CR11","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1056\/NEJM199812033392302","volume":"339","author":"WJ Burlingham","year":"1998","unstructured":"Burlingham WJ, Grailer AP, Heisey DM, et al. The effect of tolerance to noninherited maternal HLA antigens on the survival of renal transplants from sibling donors. N Engl J Med. 1998;339:1657\u201364.","journal-title":"N Engl J Med"},{"key":"2619_CR12","doi-asserted-by":"publisher","first-page":"e297","DOI":"10.1371\/journal.pmed.0040297","volume":"4","author":"JP Vandenbroucke","year":"2007","unstructured":"Vandenbroucke JP, von Elm E, Altman DG, et al. Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. PLoS Med. 2007;4:e297.","journal-title":"PLoS Med"},{"key":"2619_CR13","doi-asserted-by":"publisher","first-page":"3114","DOI":"10.1111\/ajt.12478","volume":"13","author":"C Wiebe","year":"2013","unstructured":"Wiebe C, Pochinco D, Blydt-Hansen TD, et al. Class II HLA epitope matching-a strategy to minimize de novo donor-specific antibody development and improve outcomes. Am J Transplant. 2013;13:3114\u201322.","journal-title":"Am J Transplant"},{"key":"2619_CR14","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/ajt.12968","volume":"15","author":"R Sapir-Pichhadze","year":"2015","unstructured":"Sapir-Pichhadze R, Tinckam K, Quach K, et al. HLA-DR and -DQ eplet mismatches and transplant glomerulopathy: a nested case-control study. Am J Transplant. 2015;15:137\u201348.","journal-title":"Am J Transplant"},{"key":"2619_CR15","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.humimm.2006.10.003","volume":"68","author":"RJ Duquesnoy","year":"2007","unstructured":"Duquesnoy RJ, Askar M. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. V. Eplet matching for HLA-DR, HLA-DQ, and HLA-DP. Hum Immunol. 2007;68:12\u201325.","journal-title":"Hum Immunol"},{"key":"2619_CR16","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S0198-8859(02)00381-6","volume":"63","author":"RJ Duquesnoy","year":"2002","unstructured":"Duquesnoy RJ, Marrari M. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. II. Verification of the algorithm and determination of the relative immunogenicity of amino acid triplet-defined epitopes. Hum Immunol. 2002;63:353\u201363.","journal-title":"Hum Immunol"},{"key":"2619_CR17","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S0198-8859(02)00382-8","volume":"63","author":"RJ Duquesnoy","year":"2002","unstructured":"Duquesnoy RJ. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. I. Description of the algorithm. Hum Immunol. 2002;63:339\u201352.","journal-title":"Hum Immunol"},{"key":"2619_CR18","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.humimm.2006.08.001","volume":"67","author":"RJ Duquesnoy","year":"2006","unstructured":"Duquesnoy RJ. A structurally based approach to determine HLA compatibility at the humoral immune level. Hum Immunol. 2006;67:847\u201362.","journal-title":"Hum Immunol"},{"key":"2619_CR19","doi-asserted-by":"crossref","unstructured":"Duquesnoy RJ, Marrari M, Mulder A, Sousa LC, da Silva AS, do Monte SJ. First report on the antibody verification of HLA-ABC epitopes recorded in the website-based HLA epitope registry. Tissue Antigens 2014;83:391-400.","DOI":"10.1111\/tan.12341"},{"key":"2619_CR20","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.humimm.2014.09.012","volume":"75","author":"RJ Duquesnoy","year":"2014","unstructured":"Duquesnoy RJ, Marrari M, Tambur AR, et al. First report on the antibody verification of HLA-DR, HLA-DQ and HLA-DP epitopes recorded in the HLA epitope registry. Hum Immunol. 2014;75:1097\u2013103.","journal-title":"Hum Immunol"},{"key":"2619_CR21","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.humimm.2018.11.007","volume":"80","author":"RJ Duquesnoy","year":"2019","unstructured":"Duquesnoy RJ, Marrari M, Marroquim MS, et al. Second update of the international registry of HLA epitopes. I. the HLA-ABC epitope database. Hum Immunol. 2019;80:103\u20136.","journal-title":"Hum Immunol"},{"key":"2619_CR22","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1097\/TP.0b013e3181b4a9ff","volume":"88","author":"V Kosmoliaptsis","year":"2009","unstructured":"Kosmoliaptsis V, Chaudhry AN, Sharples LD, et al. Predicting HLA class I alloantigen immunogenicity from the number and physiochemical properties of amino acid polymorphisms. Transplantation. 2009;88:791\u20138.","journal-title":"Transplantation"},{"key":"2619_CR23","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1097\/TP.0b013e3181ffff99","volume":"91","author":"V Kosmoliaptsis","year":"2011","unstructured":"Kosmoliaptsis V, Sharples LD, Chaudhry AN, Halsall DJ, Bradley JA, Taylor CJ. Predicting HLA class II alloantigen immunogenicity from the number and physiochemical properties of amino acid polymorphisms. Transplantation. 2011;91:183\u201390.","journal-title":"Transplantation"},{"key":"2619_CR24","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1111\/ajt.13707","volume":"16","author":"V Kosmoliaptsis","year":"2016","unstructured":"Kosmoliaptsis V, Mallon DH, Chen Y, Bolton EM, Bradley JA, Taylor CJ. Alloantibody responses after renal transplant failure can be better predicted by donor-recipient HLA amino acid sequence and physicochemical disparities than conventional HLA matching. Am J Transplant. 2016;16:2139\u201347.","journal-title":"Am J Transplant"},{"key":"2619_CR25","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/TP.0000000000000546","volume":"99","author":"DH Mallon","year":"2015","unstructured":"Mallon DH, Bradley JA, Winn PJ, Taylor CJ, Kosmoliaptsis V. Three-dimensional structural modelling and calculation of electrostatic potentials of HLA Bw4 and Bw6 epitopes to explain the molecular basis for alloantibody binding: toward predicting HLA antigenicity and immunogenicity. Transplantation. 2015;99:385\u201390.","journal-title":"Transplantation"},{"key":"2619_CR26","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/tan.13883","volume":"96","author":"CSM Kramer","year":"2020","unstructured":"Kramer CSM, Koster J, Haasnoot GW, Roelen DL, Claas FHJ, Heidt S. HLA-EMMA: a user-friendly tool to analyse HLA class I and class II compatibility on the amino acid level. HLA. 2020;96:43\u201351.","journal-title":"HLA"},{"key":"2619_CR27","doi-asserted-by":"publisher","first-page":"3780","DOI":"10.4049\/jimmunol.1800683","volume":"201","author":"DH Mallon","year":"2018","unstructured":"Mallon DH, Kling C, Robb M, et al. Predicting humoral alloimmunity from differences in donor and recipient HLA surface electrostatic potential. J Immunol. 2018;201:3780\u201392.","journal-title":"J Immunol"},{"key":"2619_CR28","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.humimm.2003.09.017","volume":"65","author":"MK Dankers","year":"2004","unstructured":"Dankers MK, Roelen DL, Nagelkerke NJ, et al. The HLA-DR phenotype of the responder is predictive of humoral response against HLA class I antigens. Hum Immunol. 2004;65:13\u20139.","journal-title":"Hum Immunol"},{"key":"2619_CR29","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/imm.12889","volume":"154","author":"KK Jensen","year":"2018","unstructured":"Jensen KK, Andreatta M, Marcatili P, et al. Improved methods for predicting peptide binding affinity to MHC class II molecules. Immunology. 2018;154:394\u2013406.","journal-title":"Immunology"},{"key":"2619_CR30","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.humimm.2011.07.303","volume":"72","author":"V Kosmoliaptsis","year":"2011","unstructured":"Kosmoliaptsis V, Dafforn TR, Chaudhry AN, Halsall DJ, Bradley JA, Taylor CJ. High-resolution, three-dimensional modeling of human leukocyte antigen class I structure and surface electrostatic potential reveals the molecular basis for alloantibody binding epitopes. Hum Immunol. 2011;72:1049\u201359.","journal-title":"Hum Immunol"},{"key":"2619_CR31","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.humimm.2012.12.004","volume":"74","author":"HG Otten","year":"2013","unstructured":"Otten HG, Calis JJ, Kesmir C, van Zuilen AD, Spierings E. Predicted indirectly recognizable HLA epitopes presented by HLA-DR correlate with the de novo development of donor-specific HLA IgG antibodies after kidney transplantation. Hum Immunol. 2013;74:290\u20136.","journal-title":"Hum Immunol"},{"key":"2619_CR32","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604\u201312.","journal-title":"Ann Intern Med"},{"key":"2619_CR33","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1681\/ASN.2008030287","volume":"20","author":"GJ Schwartz","year":"2009","unstructured":"Schwartz GJ, Munoz A, Schneider MF, et al. New equations to estimate GFR in children with CKD. J Am Soc Nephrol. 2009;20:629\u201337.","journal-title":"J Am Soc Nephrol"},{"key":"2619_CR34","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.2215\/CJN.01640309","volume":"4","author":"GJ Schwartz","year":"2009","unstructured":"Schwartz GJ, Work DF. Measurement and estimation of GFR in children and adolescents. Clin J Am Soc Nephrol. 2009;4:1832\u201343.","journal-title":"Clin J Am Soc Nephrol"},{"key":"2619_CR35","doi-asserted-by":"publisher","first-page":"463","DOI":"10.2215\/CJN.06300614","volume":"10","author":"V de Souza","year":"2015","unstructured":"de Souza V, Cochat P, Rabilloud M, et al. Accuracy of different equations in estimating GFR in pediatric kidney transplant recipients. Clin J Am Soc Nephrol. 2015;10:463\u201370.","journal-title":"Clin J Am Soc Nephrol"},{"key":"2619_CR36","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1681\/ASN.2009101065","volume":"21","author":"C Lefaucheur","year":"2010","unstructured":"Lefaucheur C, Loupy A, Hill GS, et al. Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation. J Am Soc Nephrol. 2010;21:1398\u2013406.","journal-title":"J Am Soc Nephrol"},{"key":"2619_CR37","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.trim.2013.05.001","volume":"28","author":"SJ Fidler","year":"2013","unstructured":"Fidler SJ, Irish AB, Lim W, Ferrari P, Witt CS, Christiansen FT. Pre-transplant donor specific anti-HLA antibody is associated with antibody-mediated rejection, progressive graft dysfunction and patient death. Transpl Immunol. 2013;28:148\u201353.","journal-title":"Transpl Immunol"},{"key":"2619_CR38","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1097\/TP.0000000000002366","volume":"102","author":"C Roufosse","year":"2018","unstructured":"Roufosse C, Simmonds N, Clahsen-van Groningen M, et al. A 2018 reference guide to the Banff classification of renal allograft pathology. Transplantation. 2018;102:1795\u2013814.","journal-title":"Transplantation"},{"key":"2619_CR39","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1681\/ASN.2014090945","volume":"26","author":"M Haas","year":"2015","unstructured":"Haas M. Transplant glomerulopathy: the view from the other side of the basement membrane. J Am Soc Nephrol. 2015;26:1235\u20137.","journal-title":"J Am Soc Nephrol"},{"key":"2619_CR40","first-page":"1195","volume":"58","author":"H Isoniemi","year":"1994","unstructured":"Isoniemi H, Taskinen E, Hayry P. Histological chronic allograft damage index accurately predicts chronic renal allograft rejection. Transplantation. 1994;58:1195\u20138.","journal-title":"Transplantation"},{"key":"2619_CR41","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1097\/01.ASN.0000054496.68498.13","volume":"14","author":"S Yilmaz","year":"2003","unstructured":"Yilmaz S, Tomlanovich S, Mathew T, et al. Protocol core needle biopsy and histologic chronic allograft damage index (CADI) as surrogate end point for long-term graft survival in multicenter studies. J Am Soc Nephrol. 2003;14:773\u20139.","journal-title":"J Am Soc Nephrol"},{"key":"2619_CR42","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1097\/00007890-199403270-00015","volume":"57","author":"AJ Matas","year":"1994","unstructured":"Matas AJ, Gillingham KJ, Payne WD, Najarian JS. The impact of an acute rejection episode on long-term renal allograft survival (t1\/2). Transplantation. 1994;57:857\u20139.","journal-title":"Transplantation"},{"key":"2619_CR43","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/ki.1991.240","volume":"40","author":"BL Kasiske","year":"1991","unstructured":"Kasiske BL, Kalil RS, Lee HS, Rao KV. Histopathologic findings associated with a chronic, progressive decline in renal allograft function. Kidney Int. 1991;40:514\u201324.","journal-title":"Kidney Int"},{"key":"2619_CR44","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/ki.1997.38","volume":"51","author":"D Seron","year":"1997","unstructured":"Seron D, Moreso F, Bover J, et al. Early protocol renal allograft biopsies and graft outcome. Kidney Int. 1997;51:310\u20136.","journal-title":"Kidney Int"},{"key":"2619_CR45","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1681\/ASN.V93482","volume":"9","author":"P Nickerson","year":"1998","unstructured":"Nickerson P, Jeffery J, Gough J, et al. Identification of clinical and histopathologic risk factors for diminished renal function 2 years posttransplant. J Am Soc Nephrol. 1998;9:482\u20137.","journal-title":"J Am Soc Nephrol"},{"key":"2619_CR46","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1111\/j.1600-6143.2008.02159.x","volume":"8","author":"K Solez","year":"2008","unstructured":"Solez K, Colvin RB, Racusen LC, et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant. 2008;8:753\u201360.","journal-title":"Am J Transplant"},{"key":"2619_CR47","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1080\/00401706.1994.10485840","volume":"36","author":"A Cutler","year":"1994","unstructured":"Cutler A, Breiman L. Archetypal analysis. Technometrics. 1994;36:338\u201347.","journal-title":"Technometrics"},{"key":"2619_CR48","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1111\/j.1399-3046.2010.01359.x","volume":"14","author":"P Icard","year":"2010","unstructured":"Icard P, Hooper SR, Gipson DS, Ferris ME. Cognitive improvement in children with CKD after transplant. Pediatr Transplant. 2010;14:887\u201390.","journal-title":"Pediatr Transplant"},{"key":"2619_CR49","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1080\/09297040600876311","volume":"12","author":"DS Gipson","year":"2006","unstructured":"Gipson DS, Hooper SR, Duquette PJ, et al. Memory and executive functions in pediatric chronic kidney disease. Child Neuropsychol. 2006;12:391\u2013405.","journal-title":"Child Neuropsychol"},{"key":"2619_CR50","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1136\/archdischild-2018-314934","volume":"104","author":"A Francis","year":"2019","unstructured":"Francis A, Didsbury MS, van Zwieten A, et al. Quality of life of children and adolescents with chronic kidney disease: a cross-sectional study. Arch Dis Child. 2019;104:134\u201340.","journal-title":"Arch Dis Child"},{"key":"2619_CR51","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1093\/ndt\/gfn537","volume":"24","author":"W Aasebo","year":"2009","unstructured":"Aasebo W, Homb-Vesteraas NA, Hartmann A, Stavem K. Life situation and quality of life in young adult kidney transplant recipients. Nephrol Dial Transplant. 2009;24:304\u20138.","journal-title":"Nephrol Dial Transplant"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-021-02619-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-021-02619-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-021-02619-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,11]],"date-time":"2023-02-11T05:06:23Z","timestamp":1676091983000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-021-02619-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,19]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["2619"],"URL":"https:\/\/doi.org\/10.1186\/s12882-021-02619-0","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,19]]},"assertion":[{"value":"22 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval granted by Sir Charles Gairdner Osborne Park Health Care Group Human Research Ethics Committee (PRN: RGS930), with reciprocal approvals for all sites in Australia. Written or verbal consents will be obtained from all participants in Australia, with the process of verbal consents approved by the ethics committee during COVID-19 pandemic.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consents will be sought with participant recruitment.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"416"}}